ArticleBiology open2025
Generation and characterization of a DYNLT1-knockout mouse model reveals electrophysiological alterations and potential mechanistic contributors to atrial fibrillation.
Article in Biology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Atrial fibrillation (AF) is a common arrhythmia that increases the risk of stroke and heart failure and is associated with high morbidity and mortality. However, its molecular pathogenesis remains incompletely understood. In this study, we generated a DYNLT1 knockout (KO) mouse model using CRISPR/Cas9 technology. Through electrocardiography, echocardiography, and histological analysis, we found that DYNLT1 deletion induced spontaneous AF. The KO mice exhibited not only surface electrophysiological remodeling and atrial structural changes but also increased atrial cardiomyocyte apoptosis, downregulation of gap junction proteins, and elevated inflammatory markers at the molecular level. Furthermore, using mass spectrometry, immunofluorescence, and other molecular techniques, we observed that DYNLT1 deletion reduced the distribution of its interacting protein TMCO1 in the endoplasmic reticulum (ER) of atrial cardiomyocytes, leading to ER calcium overload and potentially triggering the onset of AF. This study establishes a novel animal model for AF research, advances our understanding of the molecular mechanisms underlying AF, and provides a theoretical basis for the development of targeted molecular therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.